Streetbeat News

Analyst Ratings

MRCY

Mercury Sys (NASDAQ:MRCY) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average price target is $49.5, representing an upside from the current price of $36.53. This average has decreased by 14.29% from the previous average price target of $57.75.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:01 pm

FDX

Credit Suisse has maintained its Outperform rating for FedEx (NYSE:FDX) but lowered its price target from $273.00 to $265.00. FedEx shares are currently trading up 3.43% at $233.58 per share.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:01 pm

FCX

Morgan Stanley maintains its Equal-Weight rating for Freeport-McMoRan (NYSE:FCX) and raises its price target from $35.00 to $38.50. Shares of FCX are trading down 0.67% at $39.51 per share.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:01 pm

ZUO

In the last 3 months, 5 analysts have provided bullish ratings for Zuora (NYSE:ZUO) with an average 12-month price target of $14.6, a 32.73% increase from the previous average price target of $11.00.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:01 pm

MKSI

In the last quarter, MKS Instruments (NASDAQ:MKSI) received 5 bullish and 1 indifferent analyst ratings. The average 12-month price target for the stock is $106.0, with a high of $115.00 and a low of $90.00, a decrease of 1.85% from the previous average of $108.00.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:01 pm

ITCI

In the past 3 months, 14 analysts have published their opinions on Intra-Cellular Therapies (NASDAQ:ITCI) stock, with an average 12-month price target of $76.29. The average price target has increased by 3.88% over the past month.

Portfolio Pulse from Benzinga Insights

June 22, 2023 | 5:00 pm

DALXF

Raymond James analyst Jeremy Mccrea maintains a Outperform rating on Spartan Delta (OTC:DALXF) and lowers the price target from C$19 to C$6.5.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 4:58 pm

KXSCF

RBC Capital analyst Paul Treiber maintains an Outperform rating on Kinaxis (OTC:KXSCF) and raises the price target from C$210 to C$220.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 4:55 pm

NWHUF

Scotiabank analyst Mario Saric maintains a Sector Perform rating on Northwest Healthcare REIT (OTC:NWHUF) and lowers the price target from C$11 to C$9.5.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 4:52 pm

CP

Scotiabank analyst Konark Gupta maintains an Outperform rating on Canadian Pacific Kansas (NYSE:CP) and raises the price target from C$122 to C$124.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 4:47 pm